AV
Anavex
AVXL·NASDAQNew York NYFounded 200730 employees
Small CapbiotechPublicNeurology
Platform: Sigma-1
Market Cap
$0.4B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (AVXL)
Loading AVXL stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| AVX-9264 | AVX-9264 | Phase 2/3 | 1 | CD20 | ADPKDNSCLC | ||
| Pexanaritide | AVX-3662 | NDA/BLA | 1 | IL-23 | Schizophrenia |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)